Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2022 | $62.00 → $49.00 | Overweight → Neutral | Piper Sandler |
| 3/28/2022 | $80.00 → $54.00 | Outperform → Neutral | Wedbush |
| 2/24/2022 | $80.00 → $65.00 | Neutral | UBS |
| 2/4/2022 | $85.00 → $88.00 | Neutral → Outperform | Wedbush |
COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021 Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs) Increased year-to-date free cash flow by $50 million compared with the same period last year Updated full-year 2024 adjusted EBITDA outlook to a revised ra
Sleep Number Corporation (NASDAQ:SNBR) will release its fiscal third quarter results through September 28, 2024, after market close on Wednesday, October 30, 2024. Management will host its regularly scheduled conference call to discuss the company's results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations
Generated adjusted EBITDA of $28 million for the second quarter Delivered gross margin rate of 59.1% for the second quarter, up 150 basis points versus last year and ahead of expectations Reduced operating expenses by $19 million year-over-year for the quarter and $44 million year-to-date (both periods before restructuring costs) Year-to-date free cash flow increased $21 million compared with the same period last year Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million Sleep Number Corporation (NASDAQ:SNBR) today reported results for the quarter ended June 29, 2024. "The implementation of our transformative initiatives is improving gross margin
10-Q - Sleep Number Corp (0000827187) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
SC 13G/A - Sleep Number Corp (0000827187) (Subject)
SC 13G/A - Sleep Number Corp (0000827187) (Subject)
COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021 Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs) Increased year-to-date free cash flow by $50 million compared with the same period last year Updated full-year 2024 adjusted EBITDA outlook to a revised ra
Minnesota's longest tenured female public company CEO transformed mattress retailer into wellness technology company, built iconic Sleep Number brand Company also shares plans for additional Board and corporate governance changes Sleep Number Corporation (NASDAQ:SNBR) announced today that Shelly Ibach has shared her plans to retire as Chair, President and Chief Executive Officer, no later than the 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"). Pursuant to its established succession plan, the Board of Directors (the "Board") has engaged an independent executive search firm to help identify Ibach's CEO successor. To support an effective transition, Ibach will continue to s
SAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
New innovation designed to help even more couples achieve quality sleep; Sleep Number now offers three smart beds under $2,000Today, Sleep Number Corporation (NASDAQ:SNBR), the sleep wellness technology leader, unveiled its new Sleep Number® c1 smart bed at only $999 (Queen). The brand's best value, the c1 offers the same signature adjustable firmness on either side and sleep technology features as Sleep Number's higher-end smart beds. For under $1,000, sleepers receive their ideal comfort and support; breathable technology that draws heat away from the body; and personalized digital sleep health insights to help improve sleep over time. And, because only Sleep Number® smart beds are designe
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results. G-III Apparel Group posted adjusted earnings of 13 cents per share, according to data from Benzinga Pro. The company's quarterly sales came in at $609.747 million, missing market estimates of $616.286 million. G-III Apparel Group shares dipped 13.4% to $27.12 on Thursday. Here are some other stocks moving in today’s mid-day session. Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares jumped 139.4% to $2.5390. American Oncology Network, Inc. (NASDAQ:AONC) gained 102% to $4.52. American Oncology Network expanded
Minnesota's longest tenured female public company CEO transformed mattress retailer into wellness technology company, built iconic Sleep Number brand Company also shares plans for additional Board and corporate governance changes Sleep Number Corporation (NASDAQ:SNBR) announced today that Shelly Ibach has shared her plans to retire as Chair, President and Chief Executive Officer, no later than the 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"). Pursuant to its established succession plan, the Board of Directors (the "Board") has engaged an independent executive search firm to help identify Ibach's CEO successor. To support an effective transition, Ibach will continue to s
SAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th
NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Worthington Steel Inc. (NYSE:WS) will be added to the S&P SmallCap 600 effective prior to the open of trading on Friday, December 1, replacing Sleep Number Corp. (NASD: SNBR) which will be removed from the S&P SmallCap 600 effective before the open of trading on Monday, December 4. S&P SmallCap 600 constituent Worthington Industries Inc. (NYSE:WOR) is spinning off Worthington Steel in a transaction expected to be completed on December 1. Post spin-off, the parent Worthington Industries will remain in the S&P SmallCap 600 and will change its name to Worthington Enterprises Inc. It will also have a GICS sector change to Consumer Discretionary. Sleep Numb
Piper Sandler downgraded Sleep Number from Overweight to Neutral and set a new price target of $49.00 from $62.00 previously
Wedbush downgraded Sleep Number from Outperform to Neutral and set a new price target of $54.00 from $80.00 previously
UBS reiterated coverage of Sleep Number with a rating of Neutral and set a new price target of $65.00 from $80.00 previously